ISO Group Logo
Defense and Aerospace
Supply Chain Partner
A Dynatech International Company


NSN 6505-00-961-7455, 6505009617455
OXAZEPAM CAPSULES,USP

Federal Supply Classification
FSC 6505 - Drugs and Biologicals
National Item Identification Number
NIIN 009617455
Codification Country
United States
Item Name Code
INC 34195
Criticality
(X) This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
Hazardous Material Indicator Code
(P) There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product.
Availability: Request Qualified Suppliers: Currently qualifying suppliers

Manufacture or supply this part?
Join our growing community of certified suppliers.

Let Us Know
  CALL ABOUT NSN 6505-00-961-7455
Our client representatives are standing by to help fulfill your request.

+1-321-773-5710

  REQUEST QUOTE for 6505-00-961-7455


Have a list that needs to be quoted? Upload it here.

DLMS® Summary

National Stock Number 6505-00-961-7455

National Stock Number (NSN) 6505-00-961-7455, or NIIN 009617455, (oxazepam capsules,usp) was assigned May 27, 1966 in the Federal Logistics Information System (FLIS). NIIN 009617455 was cancelled on June 2, 2019, with a cancelled status of "Item is Cancelled WITHOUT Replacement." There is no known replacement specified for this stock number. This NSN does not replace any other NSNs.

There are 7 manufacturer part numbers associated with this NSN. None of the associated part number(s) are considered obsolete. The manufacturer part numbers were originally supplied by 4 suppliers. Today, 2 suppliers are listed as Active suppliers for this NSN. Of the active suppliers, there are no suppliers that are deemed design controlled or valid supply parts.

This part number has not been procured by the US Government in over 5 years.

Based on a planned procurement review by the Primary Inventory Control Activity (PICA) on Dec 01, 2020, this NSN's acquisition method was noted as: Acquire directly from the actual manufacturer, whether or not the prime contractor is the actual manufacturer. This part is a commercial/non-developmental/off-the-shelf-item. Valid AMCs: 1, 2, 3, 4 and 5.

This NSN is assigned to Item Name Code (INC) 34195. []. This item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. There is no information in the HMIRS; however, the NSN is in an FSC in Table II of Federal Standard 313 and an MSDS may be required by the user. The requirement for an MSDS is dependent on a hazard determination of the supplier or the intended end use of the product. NSN 6505009617455 does not contain precious metals.

This information was last updated on .


Technical Characteristics

UNABLE TO DECODE
(EXME) UNABLE TO DECODE
UNABLE TO DECODE
(AKJA) UNABLE TO DECODE
PRIMARY CONTAINER TYPE
(CQCT) BOTTLE
INTERMEDIATE PACKAGE QUANTITY
(PKQT) 12
UNABLE TO DECODE
(SUCB) UNABLE TO DECODE
UNABLE TO DECODE
(AJCN) UNABLE TO DECODEUNABLE TO DECODE
UNABLE TO DECODE
(CQCT) UNABLE TO DECODE
III PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) OXAZEPAM CAPSULES USP 15MG 500S PER BT
PART NAME ASSIGNED BY CONTROLLING AGENCY
(CXCY) OXAZEPAM CAPSULES USP 15MG 500S PER BT
UNABLE TO DECODE
(CYLZ) UNABLE TO DECODE
UNABLE TO DECODE
(CYLZ) UNABLE TO DECODEUNABLE TO DECODE
UNABLE TO DECODE
(PKQT) UNABLE TO DECODE
UNABLE TO DECODE
(AKJA) UNABLE TO DECODEUNABLE TO DECODE
CAPSULE TYPE
(AKJC) ANY ACCEPTABLE
CAPSULE CONTENT FORM
(CQLS) ANY ACCEPTABLE
UNABLE TO DECODE
(CXCY) UNABLE TO DECODEUNABLE TO DECODE
EXTERIOR CONTAINER WEIGHT
(ECWT) 36.00 POUNDS
EXTERIOR CONTAINER QUANTITY
(EXQT) 48
UNABLE TO DECODE
(CQLS) UNABLE TO DECODE
UNABLE TO DECODE
(ECWT) UNABLE TO DECODE
UNABLE TO DECODE
(SUWT) UNABLE TO DECODE
UNABLE TO DECODE
(EXQT) UNABLE TO DECODE
PROTECTIVE STORAGE FEATURE
(AJCN) SECURITY STORAGE
UNABLE TO DECODE
(CQCT) UNABLE TO DECODEUNABLE TO DECODE
UNABLE TO DECODE
(AKJC) UNABLE TO DECODE
EXTERIOR CONTAINER CUBIC MEASURE
(EXME) 9.00 CUBIC FEET
MEDICAL DESIGNATION AND GRADE
(MDES) UNITED STATES PHARMACOPEIA
UNABLE TO DECODE
(MDES) UNABLE TO DECODE
UNIT OF ISSUE CUBE
(SUCB) 0.020 CUBIC FEET
UNABLE TO DECODE
(AKJC) UNABLE TO DECODEUNABLE TO DECODE
UNABLE TO DECODE
(CXCY) UNABLE TO DECODE
UNABLE TO DECODE
(CQLS) UNABLE TO DECODEUNABLE TO DECODE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY
(CYLZ) 500.000
UNIT OF ISSUE WEIGHT
(SUWT) 0.75 POUNDS
UNABLE TO DECODE
(AJCN) UNABLE TO DECODE
ACTIVE MEDICAMENT MEDICINAL STRENGTH
(AKJA) 15.000 MILLIGRAMS OXAZEPAM ACTIVE INGREDIENT


Related Inventory



 
Top